Human protein C (Ceprotin)
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- May 2023
Comments
DNP: Use for prophylaxis and treatment of purpura fulminans, coumarin‑induced skin necrosis and venous thrombotic events in patients with severe congenital protein C deficiency. Await national guidance. (Decision date - May 2023)
search again